StockVS

NASDAQ · Specialty Chemicals · USD

Bon Natural Life Limited (BON) Stock Analysis

Bon Natural Life Limited (BON) is a Specialty Chemicals stock listed on NASDAQ and quoted in US Dollar.

BON

$1.16

+$0.03 (+2.84%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BON with… →

BON Key Statistics

As of Sep 4, 2026
Trading
Open
$1.12
Previous Close
$1.13
Day's Range
1.12–1.16
52-Week Range
1.05–3.40
Volume
1.50K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.24
Valuation
Market Cap
$11.80M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
2.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.63
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.74
Financials (FY)
Revenue (FY)
$18.67M−21.70%
Net Income (FY)
−$1.99M−600.98%
Profit marginThe share of revenue left as profit after all costs and taxes.
−10.68%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
6.09M
1-Year Return
−23.68%
Dividend and dates
Avg Volume
12.11K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BON Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−27.04%
2025−96.41%
2024−67.22%
2023−48.91%
2022−76.25%
2021 (partial year)−38.19%

As of September 4, 2026.

BON Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$18.67M−$1.99M−10.7%
2024$23.84M$398.17K1.7%
2023$29.52M$4.60M15.6%
2022$29.91M$6.24M20.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$18.67M$3.88M−$1.59M−$1.99M−10.7%
2024$23.84M$7.11M$1.94M$398.17K1.7%
2023$29.52M$8.84M$5.96M$4.60M15.6%
2022$29.91M$9.42M$7.91M$6.24M20.9%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

BON Valuation vs Specialty Chemicals Median

Median of 71 stocks
MetricBONSpecialty Chemicals medianvs median
P/S ratio0.631.6862% below
Profit margin−10.68%0.08%10.8 pts below

Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Bon Natural Life Limited (BON) carries a market capitalisation of $11.80M. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. The company reports 96 employees.

Over the past 52 weeks the price has ranged from $1.05 to $3.40. The most recent close on file for BON is $1.16, dated September 4, 2026. That is +$0.03 (+2.84%) against the previous close. The latest close sits 10.48% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $18.67M. That is −21.70% against the prior fiscal year, when revenue was $23.84M. The same year closed with a net loss of $1.99M. The reported profit margin is −10.68%. That is 10.8 percentage points below the Specialty Chemicals median of 0.08%. Earnings per share on a trailing basis come to −0.74.

Across the 4 fiscal years on file, revenue moves from $29.91M in 2022 to $18.67M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 2. Measured against sales, the shares trade at 0.63 times revenue. On price-to-sales that is 62.36% below the Specialty Chemicals median of 1.68. 71 Specialty Chemicals companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at −0.25. Daily returns over the trailing 5 years annualize to a volatility of 110.7%. Over the trailing twelve months the price has returned −23.68%. Across 5 years the annualized return works out at −78.67%.

Growth & Income

No dividend is on file for BON.

So far in 2026 the price is −27.04%. The strongest complete calendar year on file is 2023 at −48.91%; the weakest is 2025 at −96.41%. Of the 4 complete calendar years on file, 0 finished higher.

Peer Comparison

Bon Natural Life Limited (BON) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Bon Natural Life Limited BON $11.80M
Linde plc LIN $220.15B 30.9
The Sherwin-Williams Company SHW $81.01B 30.8
Ecolab Inc. ECL $78.29B 37.4

The Specialty Chemicals industry average P/E ratio is 28.7x. Bon Natural Life Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Specialty Chemicals Stocks

View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

View all Basic Materials stocks →

About Bon Natural Life Limited

Bon Natural Life Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China, Europe, North America, and the Middle East. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. It sells its products through direct distributors. The company serves manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company has a strategic partnership with Tigerbone Group Limited. Bon Natural Life Limited was founded in 2006 and is headquartered in Xi'an, the People's Republic of China.

Visit website →